Skip to content

Multifactor Analysis of Short term Palliation Efficacy of Percutaneous Transhepatic Cholangial Drainage for Malignant Obstructive Jaundice

Multifactor Analysis of Short·term Palliation Efficacy of Percutaneous Transhepatic Cholangial Drainage for Malignant Obstructive Jaundice

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060610
Enrollment
Unknown
Registered
2022-06-05
Start date
2022-06-13
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Obstructive Jaundice

Interventions

Group with significant effect of lowering yellowing:-
Group with poor effect of lowering yellowing:-

Sponsors

West China hospital of Sichuan university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: PTCD was performed for the first time, and external drainage, internal and external drainage or stent implantation were successfully completed. Imaging examination, clinical or postoperative pathology confirmed malignant obstructive jaundice. Bile duct dilatation was confirmed. Total bilirubin before PTCD was more than 50U mol/L.

Exclusion criteria

Exclusion criteria: Biliary tract surgery before PTCD (biliary resection or choledochostomy); Combined with more serious heart, liver, kidney, bone marrow and other major organ dysfunction; Incomplete clinical data, serious deficiency, refusal to accept relevant examination, not regular review; Patients with any cause died within 4 weeks after PTCD.

Design outcomes

Primary

MeasureTime frame
Bilirubin after PTCD;degree of yellowing reduction;complication;

Countries

China

Contacts

Public ContactBo Li
cdhxlb@126.com+86 18980601470

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026